Titre : Flavonols

Flavonols : Questions médicales fréquentes

Termes MeSH sélectionnés :

Extremities
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Flavonols : Questions médicales les plus fréquentes", "headline": "Flavonols : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Flavonols : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-18", "dateModified": "2025-02-12", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Flavonols" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Flavonoïdes", "url": "https://questionsmedicales.fr/mesh/D005419", "about": { "@type": "MedicalCondition", "name": "Flavonoïdes", "code": { "@type": "MedicalCode", "code": "D005419", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.150.266.450" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Kaempférols", "alternateName": "Kaempferols", "url": "https://questionsmedicales.fr/mesh/D044949", "about": { "@type": "MedicalCondition", "name": "Kaempférols", "code": { "@type": "MedicalCode", "code": "D044949", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.150.266.450.284.388" } } }, { "@type": "MedicalWebPage", "name": "Quercétine", "alternateName": "Quercetin", "url": "https://questionsmedicales.fr/mesh/D011794", "about": { "@type": "MedicalCondition", "name": "Quercétine", "code": { "@type": "MedicalCode", "code": "D011794", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.150.266.450.284.777" } } }, { "@type": "MedicalWebPage", "name": "Rutoside", "alternateName": "Rutin", "url": "https://questionsmedicales.fr/mesh/D012431", "about": { "@type": "MedicalCondition", "name": "Rutoside", "code": { "@type": "MedicalCode", "code": "D012431", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.150.266.450.284.888" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "O-(bêta-Hydroxyéthyl)rutosides", "alternateName": "Hydroxyethylrutoside", "url": "https://questionsmedicales.fr/mesh/D006896", "about": { "@type": "MedicalCondition", "name": "O-(bêta-Hydroxyéthyl)rutosides", "code": { "@type": "MedicalCode", "code": "D006896", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.150.266.450.284.888.500" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Flavonols", "alternateName": "Flavonols", "code": { "@type": "MedicalCode", "code": "D044948", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Changjie Xu", "url": "https://questionsmedicales.fr/author/Changjie%20Xu", "affiliation": { "@type": "Organization", "name": "Zhejiang Provincial Key Laboratory of Horticultural Plant Integrative Biology, Zhejiang University, Hangzhou 310058, China." } }, { "@type": "Person", "name": "Kunsong Chen", "url": "https://questionsmedicales.fr/author/Kunsong%20Chen", "affiliation": { "@type": "Organization", "name": "Zhejiang Provincial Key Laboratory of Horticultural Plant Integrative Biology, Zhejiang University, Hangzhou 310058, China." } }, { "@type": "Person", "name": "Xian Li", "url": "https://questionsmedicales.fr/author/Xian%20Li", "affiliation": { "@type": "Organization", "name": "Zhejiang Provincial Key Laboratory of Horticultural Plant Integrative Biology, Zhejiang University, Hangzhou 310058, China." } }, { "@type": "Person", "name": "Wei Xue", "url": "https://questionsmedicales.fr/author/Wei%20Xue", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Green Pesticide, Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, Center for R&D of Fine Chemicals, Guizhou University, Guiyang, 550025, China. wxue@gzu.edu.cn." } }, { "@type": "Person", "name": "Nguyen Xuan Nhiem", "url": "https://questionsmedicales.fr/author/Nguyen%20Xuan%20Nhiem", "affiliation": { "@type": "Organization", "name": "Institute of Marine Biochemistry, Vietnam Academy of Science and Technology, Hanoi, Vietnam." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Mangled extremity: limb salvage for reconstruction versus primary amputation.", "datePublished": "2023-10-16", "url": "https://questionsmedicales.fr/article/37909372", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MCC.0000000000001108" } }, { "@type": "ScholarlyArticle", "name": "Contemporary role of amputation for patients with extremity soft tissue sarcoma.", "datePublished": "2022-12-09", "url": "https://questionsmedicales.fr/article/36517316", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ejso.2022.12.002" } }, { "@type": "ScholarlyArticle", "name": "[\"Stop the bleeding\"-Acute bleeding control in injuries to the trunk and extremities].", "datePublished": "2023-03-29", "url": "https://questionsmedicales.fr/article/36988661", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00113-023-01309-w" } }, { "@type": "ScholarlyArticle", "name": "Catastrophic Health Expenditure in Patients with Lower-Extremity Orthopaedic Trauma.", "datePublished": "2022-12-21", "url": "https://questionsmedicales.fr/article/36729433", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2106/JBJS.22.00623" } }, { "@type": "ScholarlyArticle", "name": "Phlegmasia cerulea dolens: a swelling, cyanosis and discolouration of the extremity in the ICU.", "datePublished": "2022-11-29", "url": "https://questionsmedicales.fr/article/36446470", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bcr-2022-251973" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétérocycliques à cycles fusionnés", "item": "https://questionsmedicales.fr/mesh/D000072471" }, { "@type": "ListItem", "position": 4, "name": "Composés hétérobicycliques", "item": "https://questionsmedicales.fr/mesh/D006574" }, { "@type": "ListItem", "position": 5, "name": "Benzopyranes", "item": "https://questionsmedicales.fr/mesh/D001578" }, { "@type": "ListItem", "position": 6, "name": "4H-1-Benzopyran-4-ones", "item": "https://questionsmedicales.fr/mesh/D002867" }, { "@type": "ListItem", "position": 7, "name": "Flavonoïdes", "item": "https://questionsmedicales.fr/mesh/D005419" }, { "@type": "ListItem", "position": 8, "name": "Flavonols", "item": "https://questionsmedicales.fr/mesh/D044948" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Flavonols - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Flavonols", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Flavonols", "description": "Comment détecte-t-on les flavonols dans les aliments ?\nQuels tests mesurent les niveaux de flavonols dans le sang ?", "url": "https://questionsmedicales.fr/mesh/D044948?mesh_terms=Extremities&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Flavonols", "description": "Les flavonols provoquent-ils des symptômes ?\nQuels effets des flavonols sur la santé ?", "url": "https://questionsmedicales.fr/mesh/D044948?mesh_terms=Extremities&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Flavonols", "description": "Comment les flavonols aident-ils à prévenir les maladies ?\nQuels aliments sont riches en flavonols ?", "url": "https://questionsmedicales.fr/mesh/D044948?mesh_terms=Extremities&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Flavonols", "description": "Les flavonols sont-ils utilisés en médecine ?\nComment les flavonols aident-ils dans le traitement du cancer ?", "url": "https://questionsmedicales.fr/mesh/D044948?mesh_terms=Extremities&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Flavonols", "description": "Y a-t-il des complications liées aux flavonols ?\nLes flavonols peuvent-ils causer des effets secondaires ?", "url": "https://questionsmedicales.fr/mesh/D044948?mesh_terms=Extremities&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Flavonols", "description": "Qui devrait éviter les flavonols ?\nLes flavonols sont-ils sûrs pour les femmes enceintes ?", "url": "https://questionsmedicales.fr/mesh/D044948?mesh_terms=Extremities&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment détecte-t-on les flavonols dans les aliments ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les flavonols peuvent être détectés par chromatographie et spectrométrie de masse." } }, { "@type": "Question", "name": "Quels tests mesurent les niveaux de flavonols dans le sang ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins spécifiques peuvent quantifier les flavonols et leurs métabolites." } }, { "@type": "Question", "name": "Les flavonols provoquent-ils des symptômes ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "En général, les flavonols ne provoquent pas de symptômes, mais des allergies peuvent survenir." } }, { "@type": "Question", "name": "Quels effets des flavonols sur la santé ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les flavonols peuvent réduire l'inflammation et améliorer la santé cardiovasculaire." } }, { "@type": "Question", "name": "Comment les flavonols aident-ils à prévenir les maladies ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Ils agissent comme antioxydants, réduisant le stress oxydatif et le risque de maladies." } }, { "@type": "Question", "name": "Quels aliments sont riches en flavonols ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les oignons, le thé, les baies et le chocolat noir sont de bonnes sources de flavonols." } }, { "@type": "Question", "name": "Les flavonols sont-ils utilisés en médecine ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les flavonols sont étudiés pour leurs effets bénéfiques sur diverses maladies." } }, { "@type": "Question", "name": "Comment les flavonols aident-ils dans le traitement du cancer ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent inhiber la croissance tumorale et améliorer l'efficacité des traitements." } }, { "@type": "Question", "name": "Y a-t-il des complications liées aux flavonols ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des interactions médicamenteuses peuvent survenir, mais elles sont rares." } }, { "@type": "Question", "name": "Les flavonols peuvent-ils causer des effets secondaires ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "En général, ils sont sûrs, mais des doses élevées peuvent entraîner des troubles digestifs." } }, { "@type": "Question", "name": "Qui devrait éviter les flavonols ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes allergiques aux flavonoïdes devraient limiter leur consommation de flavonols." } }, { "@type": "Question", "name": "Les flavonols sont-ils sûrs pour les femmes enceintes ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "En général, les flavonols sont considérés comme sûrs, mais une consultation médicale est conseillée." } } ] } ] }

Sources (6813 au total)

Mangled extremity: limb salvage for reconstruction versus primary amputation.

While MESS has historically influenced limb salvage versus amputation decisions, its universal applicability remains uncertain. With trauma systems expanding and advancements in trauma care, the need ... Recent literature reflects a shift in the management of mangled extremities. Vascular surgery, plastic surgery, and technological advancements have garnered attention. The MESS's efficacy in predictin... The review underscores the evolving landscape of limb salvage decision-making, emphasizing the need for personalized, patient-centered approaches. The Ganga Hospital Score (GHS) introduces a nuanced a...

Contemporary role of amputation for patients with extremity soft tissue sarcoma.

limb-sparing surgery is the mainstream treatment for primary extremity soft tissue sarcoma (ESTS) at referral centers, following advances in surgical reconstructions and multimodal management. However... consecutive patients who underwent surgery for primary ESTS from 2006 to 2018 were extracted from a prospectively collected database at our reference center. Patients receiving amputation for either p... Among 1628 primary ESTS, 29 patients underwent primary amputation (1.8%), 22/1159 (1.9%) for upper limb and 7/469 (1.5%) for lower limb ESTS. Patients were mainly affected by grade III FNCLCC (89.6%) ... Contemporary rate of amputation for ESTS at a reference center is extremely low. Still, amputation is required in selected cases with advanced presentations, especially in elderly, frail patients....

Catastrophic Health Expenditure in Patients with Lower-Extremity Orthopaedic Trauma.

Health-care expenditures are a leading contributor to financial hardship in the United States. Traumatic orthopaedic injuries are unpredictable and result in substantial expense. Our objectives were t... We identified all isolated lower-extremity orthopaedic trauma cases at a safety-net, Level-1 trauma center from 2018 to 2020. We queried an institutional charge database to obtain total hospital charg... In our cohort of 2,535 patients, 33% experienced a risk of CHE. A risk of CHE was experienced by 99% of patients who were uninsured, 35% of patients with private insurance, 2% of patients with Medicar... One-third of patients with lower-extremity orthopaedic trauma experience a risk of CHE, with patients who are uninsured facing a disproportionately higher risk of CHE compared with patients who are in... Prognostic Level III . See Instructions for Authors for a complete description of levels of evidence....

Prognostic factors of the synovial sarcoma of the extremities: imaging does matter.

Synovial sarcomas (SS) of the extremities are rare soft tissue sarcomas that are more common in young adults. We deciphered the imaging phenotype of SS with the aim to determine if imaging could provi... This retrospective multicenter study included consecutive pediatric and adult patients with synovial sarcomas of the extremities from December 2002 to August 2020. Inclusion criteria were (i) a follow... Out of 428 patients screened for eligibility, 98 patients (mean age: 37.1 ± 15.2 years) were included (MRI: n = 98/98, CT scan: n = 34/98; 35%). The median OS was 75.25 months (IQR = 55.50-109.12) and... This study demonstrated that imaging biomarkers can be used to predict long-term outcome in patients with SS. Strikingly, the presence of calcifications on CT scan is associated with favorable outcome... • Beyond its diagnostic value, MRI is a pre-operative prognostic tool in synovial sarcomas of the extremities since the size of the lesion is an important prognostic factor. • Calcifications on CT sca...

Efficacy of the shoelace technique for extremity fasciotomy wounds due to compartment syndrome.

The shoelace technique for compartment syndrome allows application of sustained tightening tension to an entire wound and intermittent tightening of the shoelace without requiring its replacement or a... We targeted 25 patients who were diagnosed as having compartment syndrome and underwent extremity fasciotomy at our hospital from April 2012 to December 2021. The N group, comprising 12 patients treat... There were no significant differences between the two groups in patient background. Compared with the N group patients, all of the S group patients avoided skin grafting (S group: n = 0, 0%; N group: ... We considered the shoelace technique to be a useful wound closure method for fasciotomy wounds caused by compartment syndrome because it can significantly reduce the need for skin grafting and tends t...

Patient perspective on the use of carbon fibre plates for extremity fracture fixation.

Carbon fibre-reinforced polyetheretherketone (CFR-PEEK) plates represent an exciting development within trauma and orthopaedic surgery, offering advantages including radiolucency, material properties ... This was a prospective cross-sectional survey of patients undergoing surgery for a fracture of the ankle, distal femur, distal radius, or proximal humerus. Once a decision had been made to pursue oper... Ninety-nine patients were happy to participate (64 females, mean age 50). Eighty-seven patients reported that they would want a CFR-PEEK implant for their fracture, and 76 reported that they would be ... This study demonstrates that CFR-PEEK implants would be acceptable to patients undergoing fracture surgery, with high numbers of patients stating that they would be willing to participate in a randomi...